Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 4/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4405392 | 0.83 | ALDH1A1 (0.51) | ALDH1A1HDAC1HDAC6LMNANPSR1 | |
| SCHEMBL4409018 | 0.81 | ALDH1A1 (0.50) | ALDH1A1HDAC1HDAC6LMNANPSR1 | |
| SCHEMBL22069560 | 0.80 | ALDH1A1 (0.51) | ALDH1A1HDAC1HDAC6LMNANPSR1 | |
| SCHEMBL4403650 | 0.80 | ALDH1A1 (0.49) | ALDH1A1HDAC1HDAC6LMNANPSR1 | |
| SCHEMBL4406782 | 0.79 | ALDH1A1 (0.54) | ALDH1A1HDAC1HDAC6LMNANPSR1 | |
| SCHEMBL4416287 | 0.74 | ALDH1A1 (0.58) | ALDH1A1HDAC1HDAC6LMNANPSR1 | |
| SCHEMBL4407852 | 0.72 | ALDH1A1 (0.51) | ALDH1A1HDAC1HDAC6LMNANPSR1 | |
| SCHEMBL16211963 | 0.72 | ALDH1A1 (0.51) | ALDH1A1HDAC1HDAC6LMNANPSR1 | |
| SCHEMBL4412051 | 0.67 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL4408382 | 0.67 | ALDH1A1 (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0489877-B1 | ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 2-AMINO-6-PHENYL-4H-PYRAN-4-ONES | UPJOHN CO (US) | 1995-09-20 | — | — | EP | disclosed |